Cabozantinib is a potent inhibitor of multiple receptor tyrosine kinases, like VEGFR2, MET, and RET, which play important roles in tumor cell proliferation and neovascularization, and are involved in suppression of antitumor immune responses [87]. This evidence concerns the gene KDR and neoplasm.